← All stocks

Starling Oncology, Inc.

STLN Net buying

CIK 0001799191 #2884 in the set updated 17 Sep 2026

Bought (12 mo)

$2.69M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$2.81M

$2.41M on a plan · $150.34K straight out of an exercise

Sold at will

$251.17K

5 of 11 sales

Net

−$123.01K

+$2.43M against sales at will

By person

17 insiders · 27 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Chernett Jorey

10% owner

$2.69M (16)

—

+$2.69M

10,660,858

10.46%

$69.43M

+8.0%

Hively Brad

Director

—

$2.00M (2) scheduled

−$2.00M

411,976

0.4042%

$2.68M

−45.2%

Kaushal Mohit

Director

—

$335.13K (2) scheduled

−$335.13K

205,716

0.2018%

$1.34M

+69.7%

Podnos Yale

Chief Medical Officer

—

$276.43K (3) scheduled

−$276.43K

259,527

0.2546%

$1.69M

+148.7%

Pacala Mark L

Director

—

$200.00K (3)

−$200.00K

511,852

0.5022%

$3.33M

+42.2%

Carter Robert Ross

Chief Financial Officer

—

$879.32 (1)

−$879.32

649,975

0.6378%

$4.23M

−3.4%

M33 Growth I L.P.

Director

—

5,444,207

5.34%

$35.46M

−64.3%

BARASCH RICHARD A

Director

—

4,571,022

4.49%

$29.77M

+101.2%

Virnich Daniel

Chief Executive Officer

—

2,337,166

2.29%

$15.22M

+3.5%

Ling Gabriel

Director

—

333,539

0.3273%

$2.17M

+383.0%

McGeorge Anne

Director

—

332,535

0.3263%

$2.17M

+161.1%

Johnson Karen Marie

Director

—

319,410

0.3134%

$2.08M

+177.3%

Castle Jeremy

Chief Operating Officer

—

247,031

0.2424%

$1.61M

+199.6%

England Kristin

Chief Administrative Officer

—

153,780

0.1509%

$1.00M

—

Langsam Jeffrey

Chief Clinical Officer

—

127,650

0.1253%

$831.33K

—

STOLPER MARK

Director

—

56,957

0.0559%

$370.94K

—

TZOUMAKAS KIMBERLY JO

Director

—

46,301

0.0454%

$301.54K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 56

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 4

Sales straight out of an exercise 2

Sales at will 5

Transactions with no price 0

Shares from compensation/vesting 5,316,873

History held since 17 Mar 2020